APA (7th ed.) Citation

Jugder, G., Unshigbayar, O., Ichinkhorloo, P., Boldoo, T., & Purev, E. (2018). Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise between Sensitivity and Specificity. Central Asian journal of medical science, 4(3), 230-237. https://doi.org/10.24079/cajms.2018.09.009

Chicago Style (17th ed.) Citation

Jugder, Ganzug, Oyunchimeg Unshigbayar, Purevdorj Ichinkhorloo, Tsolmon Boldoo, and Erkhembulgan Purev. "Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise Between Sensitivity and Specificity." Central Asian Journal of Medical Science 4, no. 3 (2018): 230-237. https://doi.org/10.24079/cajms.2018.09.009.

MLA (9th ed.) Citation

Jugder, Ganzug, et al. "Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise Between Sensitivity and Specificity." Central Asian Journal of Medical Science, vol. 4, no. 3, 2018, pp. 230-237, https://doi.org/10.24079/cajms.2018.09.009.